Related Experiment Videos
Adiponectin in a native Canadian population experiencing rapid epidemiological transition
Anthony J G Hanley1, Philip W Connelly, Stewart B Harris
1Leadership Sinai Centre for Diabetes, Mt. Sinai Hospital, Toronto, Ontario, Canada. hanley@mshri.on.ca
Diabetes Care
|November 25, 2003
Summary
Low adiponectin levels are linked to increased cardiovascular disease (CVD) risk. This study found lower adiponectin in men and individuals with diabetes, and it correlated with obesity and insulin resistance.
Area of Science:
- Metabolic Health
- Cardiovascular Research
- Population Health
Background:
- Adiponectin, a protein hormone, plays a crucial role in regulating glucose levels and fatty acid breakdown.
- Obesity and related metabolic disorders, including type 2 diabetes and cardiovascular disease (CVD), are significant health concerns, particularly in certain populations.
- Native Canadians are experiencing a rapid increase in diabetes and CVD rates, highlighting the need for research into contributing factors.
Purpose of the Study:
- To investigate the relationship between adiponectin levels and adiposity, type 2 diabetes, and CVD risk factors.
- To examine both cross-sectional and prospective associations in a population-based study of Native Canadians.
- To understand adiponectin's role in metabolic health and disease risk within this specific demographic.
Main Methods:
- A population-based cohort was studied, collecting baseline data on glucose, insulin, adiponectin, lipids, body fat, and waist circumference.
- Oral glucose tolerance tests were administered to categorize participants into normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and diabetes groups.
- A follow-up examination was conducted on high-risk subjects to assess changes over time.
Main Results:
- Adiponectin concentrations were lower in men compared to women and in diabetic subjects compared to NGT subjects, even after adjusting for body fat and insulin resistance.
- Adiponectin showed inverse correlations with body fat, waist circumference, insulin resistance (HOMA-IR), and triglycerides, and a positive correlation with HDL cholesterol.
- Prospective analysis indicated that higher baseline adiponectin was associated with increased HDL and decreased HOMA-IR over time.
Conclusions:
- Low circulating adiponectin levels are a significant determinant of cardiovascular disease (CVD) risk.
- Adiponectin's association with metabolic parameters like insulin resistance and HDL cholesterol underscores its importance in metabolic health.
- These findings emphasize the potential of adiponectin as a biomarker for CVD risk, particularly in populations with high diabetes prevalence.